Safe and effective thrombolysis in free flap salvage: Intra-arterial urokinase infusion.

PloS one 2023 Vol.18(3) p. e0282908

Kim JH, Yoon S, Kwon H, Oh DY, Jun YJ, Moon SH

관련 도메인

Abstract

Despite the high success rate in reconstruction using free tissue transfer, flap failure is often caused by microvascular thrombosis. In a small percentage of cases with complete flap loss, a salvage procedure is performed. In the present study, the effectiveness of intra-arterial urokinase infusion through the free flap tissue was investigated to develop a protocol to prevent thrombotic failure. The retrospective study evaluated the medical records of patients who underwent salvage procedure with intra-arterial urokinase infusion after reconstruction with free flap transfer between January 2013 and July 2019. Thrombolysis with urokinase infusion was administered as salvage treatment for patients who experienced flap compromise more than 24 hours after free flap surgery. Because of an external venous drainage through the resected vein, 100,000 IU of urokinase was infused into the arterial pedicle only into the flap circulation. A total of 16 patients was included in the present study. The mean time to re-exploration was 45.4 hours (range: 24-88 hours), and the mean quantity of infused urokinase was 69,688 IU (range: 30,000-100,000 IU). 5 cases presented with both arterial and venous thrombosis, while 10 cases had only venous thrombosis and 1 case had only arterial thrombosis; in a study of 16 patients undergoing flap surgery, 11 flaps were found to have survived completely, while 2 flaps experienced transient partial necrosis and 3 were lost despite salvage efforts. In other word, 81.3% (13 of 16) of flaps survived. Systemic complications, including gastrointestinal bleeding, hematemesis, and hemorrhagic stroke, were not observed. The free flap can be effectively and safely salvaged without systemic hemorrhagic complications using high-dose intra-arterial urokinase infusion within a short period of time without systemic circulation, even in delayed salvage cases. Urokinase infusion results in successful salvage and low rate of fat necrosis.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 free flap 피판재건술 dict 5
시술 flap 피판재건술 dict 5
합병증 necrosis 괴사 dict 2
시술 microvascular 미세수술 dict 1
해부 tissue scispacy 1
해부 intra-arterial urokinase infusion scispacy 1
해부 flap tissue scispacy 1
해부 flaps scispacy 1
해부 fat scispacy 1
합병증 thrombotic scispacy 1
합병증 arterial pedicle scispacy 1
합병증 gastrointestinal scispacy 1
약물 high-dose scispacy 1
질환 thrombosis C0040053
Thrombosis
scispacy 1
질환 thrombotic failure scispacy 1
질환 Thrombolysis C0520997
Thrombolysis, function
scispacy 1
질환 venous thrombosis C0042487
Venous Thrombosis
scispacy 1
질환 gastrointestinal bleeding C0017181
Gastrointestinal Hemorrhage
scispacy 1
질환 hematemesis C0018926
Hematemesis
scispacy 1
질환 hemorrhagic stroke C5234922
Hemorrhagic Stroke
scispacy 1
질환 systemic hemorrhagic complications scispacy 1
기타 urokinase scispacy 1
기타 patients scispacy 1
기타 venous scispacy 1
기타 arterial scispacy 1

MeSH Terms

Humans; Urokinase-Type Plasminogen Activator; Free Tissue Flaps; Retrospective Studies; Thrombolytic Therapy; Thrombosis; Venous Thrombosis; Postoperative Complications; Salvage Therapy

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문